Patients’ views on using human embryonic stem cells to treat Parkinson’s disease: an interview study

Patients’ views on using human embryonic stem cells to treat Parkinson’s disease: an interview study

Abstract Background Human embryonic stem cells (hESC) as a source for the development of advanced therapy medicinal products are considered for treatment of Parkinson’s disease (PD). Research has shown promising results and opened an avenue of great importance for patients who currently lack a disea...

Full description

Bibliographic Details
Main Authors: Jennifer Drevin, Dag Nyholm, Håkan Widner, Trinette Van Vliet, Jennifer Viberg Johansson, Elena Jiltsova, Mats Hansson
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Medical Ethics
Subjects:
hESC
ATMP
Human embryonic stem cells
Advanced therapy medicinal product
Parkinson’s disease
Ethics
Online Access:https://doi.org/10.1186/s12910-022-00840-6

Internet

https://doi.org/10.1186/s12910-022-00840-6

Similar Items